期刊文献+

经皮冠状动脉介入治疗ST段抬高型心肌梗死患者预后的影响因素探究 被引量:4

Prognosis influence factors of percutaneous coronary intervention for patients with ST elevation myocardial infarction
原文传递
导出
摘要 目的:探究经皮冠状动脉介入治疗( PCI)ST段抬高型心肌梗死( STEMI)患者的预后影响因素,为改善患者预后及生存质量提供理论依据。方法选取晋城巿人民医院2007年9月至2010年4月收治的182例接受PCI治疗的STEMI患者的临床资料,按照其存活状态分为未病死组(n=105)及病死组(n=77),对两组患者的临床特点进行回顾分析对比,并将存在统计学差异的特点纳入Logistic多因素回归分析。结果单因素分析发现,两组患者年龄、症状开始至再灌注时间、性别、合并糖尿病、心肌梗死史、心功能Killip’s分级、血管病变程度及使用药物等临床特点比较差异有统计学意义( P﹤0.05);多因素回归分析发现,年龄较大、症状开始至再灌注时间较长、合并糖尿病、血管病变≥2支及未使用β-受体阻滞剂、血管紧张素转化酶抑制剂( ACEI)或血管紧张素Ⅱ受体阻滞剂(ARB)是影响影响PCI治疗STEMI患者预后的独立危险因素(P﹤0.05)。结论年龄较大、症状开始至再灌注时间较长、合并糖尿病、血管病变≥2支及未使用β-受体阻滞剂、ACEI或ARB等因素会导致STEMI患者预后较差,因此,在患者入院后应采取一切措施缩短自症状开始至再灌注时间,并积极纠正高血糖、改善心功能及使用扩血管药物,以改善患者预后,保证其生存质量。 Objective To investigate the prognosis influence factors of percutaneous coronary intervention( PCI)for ST segment elevation myocardial infarction( STEMI)factors,and provide theoretical basis for improving the prognosis and quality of life. Methods The data of 182 STEMI patients treated by PCI in the people’s hospital of Jincheng from September 2007 to April 2010 were divided into nondeath group(n=105)and death group(n=77)according to their survival state. The clinical characters were retrospectively analyzed,and characteristics of statistical difference were into multiple Logistic regression analysis. Results The single factor analysis showed that there were significant differences in the clinical features including age,the first symptom and the reperfusion time,gender,diabetes mellitus, history of myocardial infarction,cardiac function in Killip ’s classification,degree of vascular lesions and drug use(P﹤0. 05);Multiple regression analysis showed that older age,symptoms begin,to reperfusion time longer,diabetes,vascular lesions≥2 and without the use of beta blockers,ACEI or ARB were independent prognostic factors of PCI in the treatment of STEMI( P ﹤0. 05 ). Conclusions Older age, symptoms begin,to reperfusion time longer,diabetes,vascular lesions ≥2 and without the use of beta blockers,all the above factors will lead to poor outcome in patients with STEMI,therefore,after admission the patient should take all measures to shorten the symptom onset to reperfusion time,and actively correct high blood glucose,improve heart function and the use of vasodilators,in order to improve the prognosis of patients,ensure the quality of life.
作者 张海芹
出处 《中国实用医刊》 2014年第16期7-9,共3页 Chinese Journal of Practical Medicine
关键词 经皮冠状动脉介入治疗 ST段抬高型心肌梗死 预后 影响因素 Percutaneous coronary intervention ST segment elevation myocardial infarction Prognosis Influencing factors
  • 相关文献

参考文献9

二级参考文献29

  • 1马建新,郭丹杰,郑兴征,郭继鸿.急性心肌梗死患者冠脉急诊介入术后ST段回落的研究[J].临床心电学杂志,2006,15(1):22-26. 被引量:10
  • 2Toth PP, McCullough PA, Wegner MS, et al. Lipoprorein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker[J].Expert Rev Cardiovasc Ther, 2010, 8(3):425-438.
  • 3Li N, Li S, Yu C, etal. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort[J]. Postgrad Med J, 2010, 122(4): 200-205.
  • 4Mitchell SV, Elkind, Vladimir Leon, etal. High-sensitivity C-reactive protein and Lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infaretion[J]. Stroke, 2009, 40: 3233-3237.
  • 5Ryan TJ, Antman EM, Brooks NH, etal. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardil infarction. A report of the American College of Cardiology/America Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol, 1999, 34: 890-911.
  • 6Hatoum IJ, Nelson J J, Rexrode K, et al. Abstract 3605: Lipoprotein-associated phospholipase A2 and myo- cardial infarction in women. Circulation, 2007, 116: 818- 843.
  • 7Desmet WJ, Mesotten LV, Maes AF, et al. Relation between different methods for analysing ST segment deviation and infarct size as assessed by positron emission tomography[ J ]. Heart,2004,90 (8) : 887-892.
  • 8Syed MA, Botzak S, Asfour A, et al. Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infaretion[J]. Am Heart J, 2004,147(2) :275-280.
  • 9Reffelmann T, Kloner RA. Microvascular alterations after temporary coronary artery occlusion: the nofellow phenomenon [ J ]. J Cardiovasc Pharmacol Ther, 2004,9(3) :163-172.
  • 10Corbal6n R, Larmin G, NRzTxl C, et al. Association of noninvasive makers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty[ J]. Am J Cardiol, 2001,88(4) :342-346.

共引文献15

同被引文献44

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部